Calum A Hamilton
Overview
Explore the profile of Calum A Hamilton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
292
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Greenfinch G, Hamilton C, Donaghy P, Firbank M, Barnett N, Allan L, et al.
BJPsych Open
. 2024 Dec;
10(6):e223.
PMID: 39635755
The aim of this study was to determine whether there was a significant change in cardiac [123I]-metaiodobenzylguanidine uptake between baseline and follow-up in individuals with mild cognitive impairment with Lewy...
2.
Hasoon J, Hamilton C, Schumacher J, Colloby S, Donaghy P, Thomas A, et al.
Int J Geriatr Psychiatry
. 2024 Sep;
39(9):e6138.
PMID: 39261275
Background: Predicting which individuals may convert to dementia from mild cognitive impairment (MCI) remains difficult in clinical practice. Electroencephalography (EEG) is a widely available investigation but there is limited research...
3.
Hamilton C, Donaghy P, Durcan R, Ciafone J, Olsen K, Roberts G, et al.
Neurology
. 2024 Jun;
103(2):e209499.
PMID: 38870460
Background And Objectives: Retrospective studies indicate that dementia with Lewy bodies (DLB) may be preceded by a mild cognitive impairment (MCI) prodrome. Research criteria for the prospective identification of MCI...
4.
Wyman-Chick K, Chaudhury P, Bayram E, Abdelnour C, Matar E, Chiu S, et al.
Neurol Ther
. 2024 May;
13(3):885-906.
PMID: 38720013
This pragmatic review synthesises the current understanding of prodromal dementia with Lewy bodies (pDLB) and prodromal Alzheimer's disease (pAD), including clinical presentations, neuropsychological profiles, neuropsychiatric symptoms, biomarkers, and indications for...
5.
Hamilton C, Matthews F, Attems J, Donaghy P, Erskine D, Taylor J, et al.
Br J Psychiatry
. 2024 Apr;
224(6):237-244.
PMID: 38584319
Background: Multimorbidity, the presence of two or more health conditions, has been identified as a possible risk factor for clinical dementia. It is unclear whether this is due to worsening...
6.
Fernando R, Thomas A, Hamilton C, Durcan R, Barker S, Ciafone J, et al.
J Neurol Sci
. 2024 Feb;
458:122941.
PMID: 38422782
Introduction: Clinical parkinsonism is a core diagnostic feature for mild cognitive impairment with Lewy bodies (MCI-LB) but can be challenging to identify. A five-item scale derived from the Unified Parkinson's...
7.
Hamilton C, Gallagher P, Ciafone J, Barnett N, Barker S, Donaghy P, et al.
J Int Neuropsychol Soc
. 2023 Nov;
30(5):421-427.
PMID: 38017617
Objective: Attentional impairments are common in dementia with Lewy bodies and its prodromal stage of mild cognitive impairment (MCI) with Lewy bodies (MCI-LB). People with MCI may be capable of...
8.
Katanga J, Hamilton C, Walker L, Attems J, Thomas A
Brain Pathol
. 2023 Aug;
33(6):e13188.
PMID: 37551936
Age-related hearing loss frequently precedes or coexists with mild cognitive impairment and dementia. The role specific neuropathologies play in this association, as either a cause or a consequence, is unclear....
9.
Durcan R, Roberts G, Hamilton C, Donaghy P, Howe K, Colloby S, et al.
Neurology
. 2023 Jul;
101(12):e1196-e1205.
PMID: 37524532
Background And Objectives: Progressive nigrostriatal pathway degeneration occurs in individuals with dementia with Lewy bodies (LB). Our objective was to investigate whether repeat 123[I]-N-(3-fluoropropyl)-2β-carboxymethoxy-3β-(4-iodophenyl) nortropane (FP-CIT) single photon emission computed...
10.
Schumacher J, Ray N, Hamilton C, Bergamino M, Donaghy P, Firbank M, et al.
Alzheimers Dement
. 2023 Mar;
19(10):4549-4563.
PMID: 36919460
Introduction: Degeneration of cortical cholinergic projections from the nucleus basalis of Meynert (NBM) is characteristic of dementia with Lewy bodies (DLB) and Alzheimer's disease (AD), whereas involvement of cholinergic projections...